98 related articles for article (PubMed ID: 10882583)
1. Consistent and significant inhibition of human immunodeficiency virus type 1 envelope-mediated membrane fusion by beta-chemokines (RANTES) in primary human macrophages.
Stantchev TS; Broder CC
J Infect Dis; 2000 Jul; 182(1):68-78. PubMed ID: 10882583
[TBL] [Abstract][Full Text] [Related]
2. Inhibitory effects of small-molecule CCR5 antagonists on human immunodeficiency virus type 1 envelope-mediated membrane fusion and viral replication.
Takashima K; Miyake H; Furuta RA; Fujisawa JI; Iizawa Y; Kanzaki N; Shiraishi M; Okonogi K; Baba M
Antimicrob Agents Chemother; 2001 Dec; 45(12):3538-43. PubMed ID: 11709336
[TBL] [Abstract][Full Text] [Related]
3. Effect of beta-chemokines on human immunodeficiency virus type 1 replication, binding, uncoating, and CCR5 receptor expression in human monocyte-derived macrophages.
Jiang Y; Jolly PE
J Hum Virol; 1999; 2(3):123-32. PubMed ID: 10413363
[TBL] [Abstract][Full Text] [Related]
4. HIV-1 coreceptor activity of CCR5 and its inhibition by chemokines: independence from G protein signaling and importance of coreceptor downmodulation.
Alkhatib G; Locati M; Kennedy PE; Murphy PM; Berger EA
Virology; 1997 Aug; 234(2):340-8. PubMed ID: 9268166
[TBL] [Abstract][Full Text] [Related]
5. Coreceptor usage and RANTES sensitivity of non-syncytium-inducing HIV-1 isolates obtained from patients with AIDS.
Jansson M; Backström E; Björndal A; Holmberg V; Rossi P; Fenyö EM; Popovic M; Albert J; Wigzell H
J Hum Virol; 1999; 2(6):325-38. PubMed ID: 10774549
[TBL] [Abstract][Full Text] [Related]
6. Beta-chemokine inhibition of monocytotropic HIV-1 infection. Interference with a postbinding fusion step.
Oravecz T; Pall M; Norcross MA
J Immunol; 1996 Aug; 157(4):1329-32. PubMed ID: 8759710
[TBL] [Abstract][Full Text] [Related]
7. Macrophages and lymphocytes differentially modulate the ability of RANTES to inhibit HIV-1 infection.
Gross E; Amella CA; Pompucci L; Franchin G; Sherry B; Schmidtmayerova H
J Leukoc Biol; 2003 Nov; 74(5):781-90. PubMed ID: 12960233
[TBL] [Abstract][Full Text] [Related]
8. [Chemokine receptors and its importance in the replication cycle of human immunodeficiency virus: clinical and therapeutic implications].
Azevedo-Pereira JM; Santos-Costa Q
Acta Med Port; 2008; 21(5):497-504. PubMed ID: 19187693
[TBL] [Abstract][Full Text] [Related]
9. GM-CSF and M-CSF modulate beta-chemokine and HIV-1 expression in microglia.
Si Q; Cosenza M; Zhao ML; Goldstein H; Lee SC
Glia; 2002 Aug; 39(2):174-83. PubMed ID: 12112368
[TBL] [Abstract][Full Text] [Related]
10. The role of cholesterol and sphingolipids in chemokine receptor function and HIV-1 envelope glycoprotein-mediated fusion.
Ablan S; Rawat SS; Viard M; Wang JM; Puri A; Blumenthal R
Virol J; 2006 Dec; 3():104. PubMed ID: 17187670
[TBL] [Abstract][Full Text] [Related]
11. Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4.
Boutet A; Salim H; Taoufik Y; Lledo PM; Vincent JD; Delfraissy JF; Tardieu M
Glia; 2001 May; 34(3):165-77. PubMed ID: 11329179
[TBL] [Abstract][Full Text] [Related]
12. Soluble glycosaminoglycans Do not potentiate RANTES antiviral activity on the infection of primary macrophages by human immunodeficiency virus type 1.
Ylisastigui L; Bakri Y; Amzazi S; Gluckman JC; Benjouad A
Virology; 2000 Dec; 278(2):412-22. PubMed ID: 11118364
[TBL] [Abstract][Full Text] [Related]
13. Generation and properties of a human immunodeficiency virus type 1 isolate resistant to the small molecule CCR5 inhibitor, SCH-417690 (SCH-D).
Marozsan AJ; Kuhmann SE; Morgan T; Herrera C; Rivera-Troche E; Xu S; Baroudy BM; Strizki J; Moore JP
Virology; 2005 Jul; 338(1):182-99. PubMed ID: 15935415
[TBL] [Abstract][Full Text] [Related]
14. Is decreased HIV-1 infectivity of placental macrophages caused by high levels of beta-chemokines?
Meléndez J; García V; Sánchez E; Delgado R; Torres G; Meléndez-Guerrero LM
Cell Mol Biol (Noisy-le-grand); 2001; 47 Online Pub():OL51-9. PubMed ID: 11936874
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of respiratory syncytial virus infection with the CC chemokine RANTES (CCL5).
Elliott MB; Tebbey PW; Pryharski KS; Scheuer CA; Laughlin TS; Hancock GE
J Med Virol; 2004 Jun; 73(2):300-8. PubMed ID: 15122808
[TBL] [Abstract][Full Text] [Related]
16. Roles of chemokines and chemokine receptors in HIV-1 infection.
Murakami T; Yamamoto N
Int J Hematol; 2000 Dec; 72(4):412-7. PubMed ID: 11197206
[TBL] [Abstract][Full Text] [Related]
17. HIV-1 Env-chemokine receptor interactions in primary human macrophages: entry and beyond.
Collman RG
Res Initiat Treat Action; 2003; 8(2):6-9. PubMed ID: 12845769
[TBL] [Abstract][Full Text] [Related]
18. Chemokine (C-C motif) receptor 5-using envelopes predominate in dual/mixed-tropic HIV from the plasma of drug-naive individuals.
Irlbeck DM; Amrine-Madsen H; Kitrinos KM; Labranche CC; Demarest JF
AIDS; 2008 Jul; 22(12):1425-31. PubMed ID: 18614865
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of CCR5-mediated infection by diverse R5 and R5X4 HIV and SIV isolates using novel small molecule inhibitors of CCR5: effects of viral diversity, target cell and receptor density.
Willey S; Peters PJ; Sullivan WM; Dorr P; Perros M; Clapham PR
Antiviral Res; 2005 Nov; 68(2):96-108. PubMed ID: 16157392
[TBL] [Abstract][Full Text] [Related]
20. R5 HIV gp120-mediated cellular contacts induce the death of single CCR5-expressing CD4 T cells by a gp41-dependent mechanism.
Blanco J; Barretina J; Clotet B; Esté JA
J Leukoc Biol; 2004 Oct; 76(4):804-11. PubMed ID: 15258189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
